Novel approaches to epigenetic therapies: from drug combinations to epigenetic editing

A Majchrzak-Celińska, A Warych, M Szoszkiewicz - Genes, 2021 - mdpi.com
Cancer development involves both genetic and epigenetic alterations. Aberrant epigenetic
modifications are reversible, allowing excellent opportunities for therapeutic intervention …

Multiple myeloma: challenges encountered and future options for better treatment

S Das, N Juliana, NAA Yazit, S Azmani… - International Journal of …, 2022 - mdpi.com
Multiple myeloma (MM) is a malignant hematological disease. The disease is characterized
by the clonal proliferation of malignant plasma cells in the bone marrow. MM accounts for …

Rosmanol and carnosol synergistically alleviate rheumatoid arthritis through inhibiting TLR4/NF-κB/MAPK pathway

L Li, Z Pan, D Ning, Y Fu - Molecules, 2021 - mdpi.com
Callicarpa longissima has been used as a Yao folk medicine to treat arthritis for years in
China, although its active anti-arthritic moieties have not been clarified so far. In this study …

Anticancer Drug Discovery based on Natural products: from computational approaches to Clinical studies

P Chunarkar-Patil, M Kaleem, R Mishra, S Ray… - Biomedicines, 2024 - mdpi.com
Globally, malignancies cause one out of six mortalities, which is a serious health problem.
Cancer therapy has always been challenging, apart from major advances in …

Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements

D Singh, MA Khan, HR Siddique - Epigenomics, 2023 - Taylor & Francis
Epigenetic changes play a significant role in cancer progression, maintenance and therapy
resistance. Generally, epigenetic modifications are reversible, thereby gaining attention for …

[HTML][HTML] Zingiberene, a non-zinc-binding class I HDAC inhibitor: A novel strategy for the management of neuropathic pain

V Borgonetti, P Governa, F Manetti, N Galeotti - Phytomedicine, 2023 - Elsevier
Abstract Background Even though numerous Histone deacetylase inhibitors (HDACi) have
been approved for the treatment of different types of cancer, and others are in clinical trials …

DNA methylation signatures of bone metabolism in osteoporosis and osteoarthritis aging-related diseases: an updated review

VV Visconti, I Cariati, S Fittipaldi, R Iundusi… - International Journal of …, 2021 - mdpi.com
DNA methylation is one of the most studied epigenetic mechanisms that play a pivotal role in
regulating gene expression. The epigenetic component is strongly involved in aging-bone …

Advanced bioinformatics tools in the pharmacokinetic profiles of natural and synthetic compounds with anti-diabetic activity

AM Udrea, G Gradisteanu Pircalabioru, AA Boboc… - Biomolecules, 2021 - mdpi.com
Diabetes represents a major health problem, involving a severe imbalance of blood sugar
levels, which can disturb the nerves, eyes, kidneys, and other organs. Diabes management …

D-type cyclins in development and disease

M Saleban, EL Harris, JA Poulter - Genes, 2023 - mdpi.com
D-type cyclins encode G1/S cell cycle checkpoint proteins, which play a crucial role in
defining cell cycle exit and progression. Precise control of cell cycle exit is vital during …

Mechanistic insights into harmine-mediated inhibition of human DNA methyltransferases and prostate cancer cell growth

CC Cho, CJ Lin, HH Huang, WZ Yang… - ACS Chemical …, 2023 - ACS Publications
Mammalian DNA methyltransferases (DNMTs), including DNMT1, DNMT3A, and DNMT3B,
are key DNA methylation enzymes and play important roles in gene expression regulation …